| Primary |
| Hypertension |
75.3% |
| Diabetes Mellitus |
7.0% |
| Cardiac Failure |
1.8% |
| Hyperlipidaemia |
1.6% |
| Coronary Artery Disease |
1.5% |
| Hypercholesterolaemia |
1.3% |
| Hyperuricaemia |
1.3% |
| Atrial Fibrillation |
1.2% |
| Depression |
1.2% |
| Type 2 Diabetes Mellitus |
1.1% |
| Blood Pressure |
0.9% |
| Hypothyroidism |
0.8% |
| Cardiac Failure Chronic |
0.8% |
| Cardiac Disorder |
0.7% |
| Proteinuria |
0.6% |
| Angina Pectoris |
0.6% |
| Myocardial Ischaemia |
0.6% |
| Prophylaxis |
0.6% |
| Dyslipidaemia |
0.5% |
| Oedema |
0.5% |
|
| Renal Failure |
11.0% |
| Death |
10.4% |
| Renal Impairment |
9.5% |
| Renal Failure Acute |
6.8% |
| Vomiting |
6.2% |
| Cerebrovascular Accident |
5.5% |
| Tachycardia |
5.0% |
| Blood Pressure Increased |
4.9% |
| Dyspnoea |
4.8% |
| Hyponatraemia |
4.4% |
| Blood Creatinine Increased |
4.1% |
| Hypertension |
3.6% |
| Myocardial Infarction |
3.6% |
| Hyperkalaemia |
3.3% |
| Cardiac Failure |
3.1% |
| Hypertensive Crisis |
2.9% |
| Renal Disorder |
2.9% |
| Proteinuria |
2.7% |
| Syncope |
2.7% |
| Rash |
2.6% |
|
| Secondary |
| Hypertension |
64.0% |
| Diabetes Mellitus |
8.1% |
| Product Used For Unknown Indication |
4.6% |
| Coronary Artery Disease |
2.9% |
| Cardiac Failure |
2.8% |
| Hyperlipidaemia |
2.7% |
| Type 2 Diabetes Mellitus |
2.2% |
| Hypercholesterolaemia |
1.4% |
| Hyperuricaemia |
1.3% |
| Depression |
1.2% |
| Proteinuria |
1.2% |
| Atrial Fibrillation |
1.1% |
| Blood Pressure |
1.1% |
| Cardiac Disorder |
0.9% |
| Prophylaxis |
0.8% |
| Angina Pectoris |
0.8% |
| Hypothyroidism |
0.8% |
| Oedema |
0.8% |
| Chronic Obstructive Pulmonary Disease |
0.6% |
| Hypertriglyceridaemia |
0.6% |
|
| Blood Pressure Increased |
11.1% |
| Death |
7.9% |
| Renal Impairment |
7.9% |
| Tachycardia |
6.3% |
| Tinnitus |
5.5% |
| Dyspnoea |
5.1% |
| Hyponatraemia |
4.7% |
| Hyperkalaemia |
4.3% |
| Hypertension |
4.3% |
| Hypertensive Crisis |
4.3% |
| Angina Pectoris |
4.0% |
| Cerebrovascular Accident |
4.0% |
| Liver Injury |
4.0% |
| Syncope |
4.0% |
| Tremor |
4.0% |
| Urticaria |
4.0% |
| Weight Decreased |
4.0% |
| Blood Creatinine Increased |
3.6% |
| Blood Pressure Systolic Increased |
3.6% |
| Oedema Peripheral |
3.6% |
|
| Concomitant |
| Hypertension |
30.6% |
| Product Used For Unknown Indication |
26.2% |
| Cardiac Failure Chronic |
4.4% |
| Diabetes Mellitus |
4.2% |
| Drug Use For Unknown Indication |
4.0% |
| Osteoporosis |
3.4% |
| Nephrogenic Anaemia |
3.0% |
| Rheumatoid Arthritis |
3.0% |
| Type 2 Diabetes Mellitus |
2.8% |
| B-cell Lymphoma |
2.7% |
| Prophylaxis |
2.5% |
| Atrial Fibrillation |
2.2% |
| Myocardial Infarction |
1.9% |
| Hypercholesterolaemia |
1.6% |
| Insomnia |
1.4% |
| Diabetic Nephropathy |
1.3% |
| Systemic Lupus Erythematosus |
1.3% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Glomerulonephritis Chronic |
1.2% |
| Pain |
1.1% |
|
| Weight Decreased |
9.1% |
| Pneumonia |
8.1% |
| Renal Impairment |
8.1% |
| Hypertension |
6.1% |
| Hyponatraemia |
5.1% |
| Renal Failure Acute |
5.1% |
| Tremor |
5.1% |
| Vomiting |
5.1% |
| Blood Pressure Increased |
4.0% |
| Constipation |
4.0% |
| Dizziness |
4.0% |
| Hypotension |
4.0% |
| Myelodysplastic Syndrome |
4.0% |
| Pulmonary Embolism |
4.0% |
| Renal Pain |
4.0% |
| Rhinorrhoea |
4.0% |
| Shock |
4.0% |
| Sleep Disorder |
4.0% |
| Urinary Tract Infection |
4.0% |
| Venous Thrombosis |
4.0% |
|
| Interacting |
| Hypertension |
49.2% |
| Prophylaxis |
11.5% |
| Depression |
8.2% |
| Atrial Fibrillation |
4.9% |
| Product Used For Unknown Indication |
4.9% |
| Autoimmune Thyroiditis |
3.3% |
| Cardiac Disorder |
3.3% |
| Epilepsy |
3.3% |
| Type 2 Diabetes Mellitus |
3.3% |
| Diabetes Mellitus |
1.6% |
| Headache |
1.6% |
| Influenza Like Illness |
1.6% |
| Malaise |
1.6% |
| Thrombosis Prophylaxis |
1.6% |
|
| International Normalised Ratio Increased |
28.0% |
| Malaise |
8.0% |
| Renal Failure Acute |
8.0% |
| Wrong Technique In Drug Usage Process |
8.0% |
| Bundle Branch Block Left |
4.0% |
| Drug Interaction |
4.0% |
| Hyperkalaemia |
4.0% |
| Hypotension |
4.0% |
| Myalgia |
4.0% |
| Pain In Extremity |
4.0% |
| Renal Failure |
4.0% |
| Renal Impairment |
4.0% |
| Renin Increased |
4.0% |
| Stent Placement |
4.0% |
| Vomiting |
4.0% |
| Weight Increased |
4.0% |
|
